Federal grants to Oncotab, Inc.
Oncotab, Inc. in Waxhaw, North Carolina received $1.1 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Cancer Treatment Research, with $660,588. In fiscal 2025 it was awarded $400,000.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$1.1 million
- Awards3
- Awarded in FY 2025$400,000
- Largest award$400,000
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $660,588 |
| FY 2022 | 0 | $0 |
| FY 2023 | 0 | $0 |
| FY 2024 | 0 | $0 |
| FY 2025 | 1 | $400,000 |
Programs that fund Oncotab, Inc.
| Program | Awards | Amount |
|---|---|---|
| Cancer Treatment Research | 2 | $660,588 |
| Cancer Detection and Diagnosis Research | 1 | $400,000 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $1.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Optimized targeted radiotherapy of pancreatic cancer - abstract pancreatic ductal adenocarcinoma (PDAC) has a 5-YEAR survival rate of less than 9% and is on track to become the 2nd leading cause of cancer deaths by 2030. This poor statistic is primarily due to the difficulty in screening for pancrea | Cancer Treatment Research | May 22, 2025 | $400,000 |
| An integrated strategy using a serum and imaging biomarker for the early detection of pancreatic cancer. - abstract pancreatic ductal adenocarcinoma (PDAC) has a 5-YEAR survival rate of only 6% and diagnosis at an earlier resectable stage improves survival rates: > 30% for node negative tumors < 2 c | Cancer Detection and Diagnosis Research | September 21, 2021 | $400,000 |
| The use of TMUC1/CD3 bispecific antibody to control pancreatic ductal adenocarcinoma - bispecific antibodies (BSABS) are an emerging cancer immunotherapy strategy to re-engage immune effectors with tumor cells thus to promote immune synapse formation and induce tumor cytolysis. The bsabs target tumo | Cancer Treatment Research | September 24, 2021 | $260,588 |
Questions people ask
How much federal grant money does Oncotab, Inc. get?
$1.1 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Oncotab, Inc. the most?
The Department of Health and Human Services, with $1.1 million in 3 awards.
What is Oncotab, Inc.'s largest federal grant?
$400,000 under Cancer Treatment Research, with its first action in the period on May 22, 2025. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Oncotab, Inc.?
Its largest are Cancer Treatment Research and Cancer Detection and Diagnosis Research.
Largest federal grant recipients in North Carolina · Federal grants in North Carolina